Current Value of Holding

$0

Shares

0

% of Portfolio

0.00%

Average Buy Price

$1.62

Avg closing price
Price range

11 Jim Simons PhaseBio Pharmaceuticals Trades

The first PhaseBio Pharmaceuticals trade was made in Q3 2019. Since then Jim Simons bought shares four more times and sold shares on six occasions. The investor sold all their shares in Q2 2022 and doesn't own any shares in PhaseBio Pharmaceuticals anymore.

Avg closing price
Price range
Sold -89.3k shares Q2 2022
Avg closing price $0.96
Price range $0.52 - $1.59
New holding (+89.3k shares) Q1 2022
Avg closing price $1.62
Price range $0.97 - $2.66
Sold -101k shares Q4 2021
Avg closing price $3.02
Price range $1.90 - $4.05
New holding (+101k shares) Q3 2021
Avg closing price $3.34
Price range $2.72 - $3.85
Sold -83.4k shares Q1 2021
Avg closing price $4.06
Price range $3.25 - $5.54
New holding (+83.4k shares) Q4 2020
Avg closing price $3.58
Price range $2.73 - $4.44
Sold -132k shares Q3 2020
Avg closing price $4.03
Price range $3.17 - $5.49
Sold 19.4% shares (-31.7k shares) Q2 2020
Avg closing price $4.43
Price range $2.85 - $6.02
New holding (+163k shares) Q1 2020
Avg closing price $4.58
Price range $2.68 - $6.79
Sold -56.2k shares Q4 2019
Avg closing price $4.12
Price range $3.19 - $7.35
New holding (+56.2k shares) Q3 2019
Avg closing price $7.97
Price range $3.91 - $13.88

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!